A time to raise awareness about the disease, its prevention and treatment options. Colorectal cancer starts in the colon or ...

The city of Anniston will host a ribbon-cutting ceremony on April 24 to celebrate the grand opening of the extension of the Chief Ladiga Trail. The event coincides ...

A group of high school students at Ohio's Woodward Career Technical High School have created a touching tribute to honor the ...

"Pretty much as soon as I learned that cancer would kill me quite soon, I had this real intense desire to raise awareness of ...

While breast cancer is rare in men, the disease can affect men too. Men can also have breast lumps and should get a prompt medical evaluation for any lump or change in the appearance of their chest or ...

But my blood smear showed smudge cells, a hallmark of chronic lymphocytic leukemia—CLL. Like most people diagnosed with CLL, I had no symptoms to suggest cancer. Despite quickly catching up on the ...

The Cancer in Young People in Canada (CYP-C) program is a national, population-based surveillance system studying all children and youth diagnosed with cancer in Canada. CYP-C collects information on ...

Cancer peptide vaccination represents a promising therapeutic ... report on its successful application in a Phase II clinical trial in patients with chronic lymphocytic leukemia (CLL) after first-line ...

Visit the American Cancer Society's Cancer Statistics Center for more key statistics. Written by References Developed by the American Cancer Society medical and editorial content team with medical ...

Edward Ratner, 68, a geriatrician, husband, father and grandfather in Minneapolis, has had chronic lymphocytic leukemia for a decade. Here, he shares his story—and his rules for success.

AML and ALL are staged based on how cancer cells look under a microscope and the type of cells involved. ALL and CLL are staged based on the WBC count at the time of diagnosis. The presence of ...

Researchers compared these treatments in the phase 3 AMPLIFY trial. The trial enrolled adults with CLL who did not have a 17p deletion or TP53 mutation. Patients were randomly assigned to receive ...